Laying Out ADC CQAs & Understanding Regulatory Quality Perspectives as Complex Biologic & Small Molecule Therapies
- Contextualizing CQA requirements from approved and marketed ADCs
- Breaking down CQA considerations across small molecules and biologic ADC components
- Supplementing CQA expectations with regulatory CMC guidance from available health authority published guidelines